Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey.
Sharon McGeeMashari AlzahraniLisa VandermeerKatherine ColeGail LarocqueArif AwanBrian HuttonGregory PondDeanna SaundersMark ClemonsPublished in: Breast cancer research and treatment (2021)
Questions around optimal use of adjuvant bisphosphonates in patients with EBC still exist. There is interest among physicians in performing trials of de-escalation of these agents. The results of this survey will assist in designing pragmatic clinical trials to address this question.